Categories: News

LaunchPad Café Ltd. Announces Closing of Transaction with Ventana Biotech, Inc. (VNTA)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LaunchPad Café Ltd. Announces Closing of Transaction with Ventana Biotech, Inc. (VNTA)

LaunchPad Café Ltd. announces that it has closed its previously announced transaction with Ventana Biotech, Inc. (OTC:VNTA) pursuant to which VNTA has purchased 100% of LaunchPad’s shares in exchange for shares in VNTA -  www.launchpadcafe.net.LaunchPad Café Ltd. announces that it has closed its previously announced transaction with Ventana Biotech, Inc. (OTC:VNTA) pursuant to which VNTA has purchased 100% of LaunchPad’s shares in exchange for shares in VNTA -  www.launchpadcafe.net.
LaunchPad Café Ltd. announces that it has closed its previously announced transaction with Ventana Biotech, Inc. (OTC:VNTA) pursuant to which VNTA has purchased 100% of LaunchPad’s shares in exchange for shares in VNTA – www.launchpadcafe.net.

DENVER, June 25, 2021 (GLOBE NEWSWIRE) — LaunchPad Café Ltd. announces that it has closed its previously announced transaction with Ventana Biotech, Inc. (OTC:VNTA) pursuant to which VNTA has purchased 100% of LaunchPad’s shares in exchange for shares in VNTA.

Mr. Stephen Replin, new President and CEO of VNTA and President of LaunchPad Café said, “We are pleased to announce the closing of this important transaction for VNTA. We are now working to update the publicly available financial information for the VNTA on OTCMarkets.com The immediate goals are getting to ‘Yield Sign’ within the next two weeks and ‘Pink Current Reporting’ by mid-August. We also anticipate changing the Company’s name sometime in the coming months.”

About Ventana Biotech, Inc.:

Ventana Biotech, Inc. (OTC:VNTA) is a publicly traded Nevada company making acquisitions in the fintech and traditional specialty finance space.

About LaunchPad Café Ltd.:

LaunchPad Café, Ltd., a specialty finance Company, makes alternative funding available to entrepreneurs who are starting and growing businesses, and to those who have investment opportunities. In all cases, the two characteristics that are anticipated to be common among most borrowers from LaunchPad are that they are essentially “unbankable,” and the second is that they need to close on their funding quickly. Mr. Replin, CEO of LaunchPad Café Ltd. is the author of the book “Where to Go when The Bank Says No” –www.launchpadcafe.net.

Forward Looking Statements:

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are subject to uncertainty and may not come to fruition. Readers are cautioned not to place undue reliance on any forward-looking statement including statements that list numbers and dates.

Contact:
Stephen Replin, CEO
Stevereplin@launchpadcafe.net
303.916.3479

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2842695f-3568-44e8-b774-b2b787c8684e

Staff

Recent Posts

Alcon Publishes Agenda for 2025 Annual General Meeting

Alcon welcomes its shareholders to its third in-person AGM Alcon Board of Directors proposes to…

2 hours ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

2 hours ago

BIZCLIK MEDIA PUBLISHES APRIL EDITION OF HEALTHCARE DIGITAL

The April edition of Healthcare Digital features exclusive insights from leaders at Abzena, Arcutis Biotherapeutics, Spotfire, S&P…

2 hours ago

TALON selects Litchfield Underwriters to provide Comprehensive Stop-Loss Coverage for Transformative Equitable Healthcare Pricing Network

PORTSMOUTH, N.H., April 4, 2025 /PRNewswire/ -- Litchfield Underwriters, industry leaders in providing superior self-funded…

2 hours ago

Google Cloud and Ai2 Commit $20M to Advance AI-Powered Research for the Cancer AI Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and…

2 hours ago

Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel…

2 hours ago